Logo image of FHYD.CA

FIRST HYDROGEN CORP (FHYD.CA) Stock Fundamental Analysis

Canada - TSX-V:FHYD - CA32057N1042 - Common Stock

0.5 CAD
-0.01 (-1.96%)
Last: 9/25/2025, 7:00:00 PM
Fundamental Rating

0

FHYD gets a fundamental rating of 0 out of 10. The analysis compared the fundamentals against 23 industry peers in the Machinery industry. FHYD may be in some trouble as it scores bad on both profitability and health. FHYD is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

FHYD had negative earnings in the past year.
In the past year FHYD has reported a negative cash flow from operations.
FHYD had negative earnings in each of the past 5 years.
In the past 5 years FHYD always reported negative operating cash flow.
FHYD.CA Yearly Net Income VS EBIT VS OCF VS FCFFHYD.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 -5M -10M -15M

1.2 Ratios

The Return On Assets of FHYD (-277.76%) is worse than 95.65% of its industry peers.
Industry RankSector Rank
ROA -277.76%
ROE N/A
ROIC N/A
ROA(3y)-335.27%
ROA(5y)-241.34%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
FHYD.CA Yearly ROA, ROE, ROICFHYD.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -2K -4K -6K

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for FHYD so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
FHYD.CA Yearly Profit, Operating, Gross MarginsFHYD.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 -200 -400 -600 -800

More info and screens

0

2. Health

2.1 Basic Checks

The number of shares outstanding for FHYD has been increased compared to 1 year ago.
FHYD has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, FHYD has a worse debt to assets ratio.
FHYD.CA Yearly Shares OutstandingFHYD.CA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M
FHYD.CA Yearly Total Debt VS Total AssetsFHYD.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1M 2M 3M 4M 5M

2.2 Solvency

Based on the Altman-Z score of -42.20, we must say that FHYD is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -42.20, FHYD is doing worse than 95.65% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -42.2
ROIC/WACCN/A
WACCN/A
FHYD.CA Yearly LT Debt VS Equity VS FCFFHYD.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -5M -10M

2.3 Liquidity

FHYD has a Current Ratio of 0.14. This is a bad value and indicates that FHYD is not financially healthy enough and could expect problems in meeting its short term obligations.
FHYD has a worse Current ratio (0.14) than 91.30% of its industry peers.
FHYD has a Quick Ratio of 0.14. This is a bad value and indicates that FHYD is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of FHYD (0.11) is worse than 86.96% of its industry peers.
Industry RankSector Rank
Current Ratio 0.14
Quick Ratio 0.11
FHYD.CA Yearly Current Assets VS Current LiabilitesFHYD.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2M 4M 6M

More info and screens

0

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 56.05% over the past year.
EPS 1Y (TTM)56.05%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%46.62%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
FHYD.CA Yearly Revenue VS EstimatesFHYD.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 100K 200K 300K

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

FHYD reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
FHYD.CA Price Earnings VS Forward Price EarningsFHYD.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
FHYD.CA Per share dataFHYD.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share -0.05 -0.1 -0.15

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

FHYD does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

FIRST HYDROGEN CORP

TSX-V:FHYD (9/25/2025, 7:00:00 PM)

0.5

-0.01 (-1.96%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners1.03%
Inst Owner ChangeN/A
Ins Owners1.94%
Ins Owner ChangeN/A
Market Cap24.83M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.07
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.18
FCFYN/A
OCF(TTM)-0.18
OCFYN/A
SpS0
BVpS-0.11
TBVpS-0.13
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -277.76%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-335.27%
ROA(5y)-241.34%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 140.97%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.14
Quick Ratio 0.11
Altman-Z -42.2
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)56.05%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%46.62%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y60.59%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y33.43%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y34.58%
OCF growth 3YN/A
OCF growth 5YN/A